• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2.

作者信息

Itoh Tatsuya, Itagaki Shirou, Sumi Yoshinobu, Hirano Takeshi, Takemoto Isao, Iseki Ken

机构信息

Department of Pharmacy, Sapporo Social Insurance General Hospital, Chuo 2-jo, 6-chome, Atsubetsu-ku, Sapporo 004-8618, Japan.

出版信息

Cancer Chemother Pharmacol. 2005 May;55(5):420-4. doi: 10.1007/s00280-004-0937-4. Epub 2004 Nov 23.

DOI:10.1007/s00280-004-0937-4
PMID:15565324
Abstract

PURPOSE

The aim of this study was to investigate the transport mechanisms of transporters that contribute to the intestinal uptake of 7-ethyl-10-hydroxycamptothecin (SN-38).

METHODS

Human intestinal epithelial Caco-2 cells were used to investigate the mechanistic basis of transepithelial uptake of SN-38. We investigated the characteristics of SN-38 uptake into Caco-2 cells. The effects of baicalin and sulfobromophthalein (BSP) on the uptake of SN-38 by Caco-2 cells were examined.

RESULTS

Uptake of SN-38 was significantly reduced at 4 degrees C. Baicalin inhibited the uptake of SN-38 in a concentration-dependent manner. BSP significantly reduced the uptake of SN-38. However, probenecid, pravastatin and grepafloxacin did not affect the uptake of SN-38.

CONCLUSIONS

The results suggest that a specific transport system mediates the uptake of SN-38 across the apical membrane in Caco-2 cells.

摘要

相似文献

1
Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2.
Cancer Chemother Pharmacol. 2005 May;55(5):420-4. doi: 10.1007/s00280-004-0937-4. Epub 2004 Nov 23.
2
Involvement of specific transport system on uptake of lactone form of SN-38 in human intestinal epithelial cell line Caco-2.特定转运系统对人肠上皮细胞系 Caco-2 摄取 SN-38 内酯型的影响。
Biol Pharm Bull. 2012;35(1):54-8. doi: 10.1248/bpb.35.54.
3
Secretory transport of irinotecan metabolite SN-38 across isolated intestinal tissue.伊立替康代谢物SN - 38经离体肠组织的分泌转运。
Cancer Chemother Pharmacol. 2005 May;55(5):502-6. doi: 10.1007/s00280-004-0948-1. Epub 2005 Feb 12.
4
[Pharmacokinetic study of cancer chemotherapy].癌症化疗的药代动力学研究
Yakugaku Zasshi. 2006 Sep;126(9):723-35. doi: 10.1248/yakushi.126.723.
5
Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells.伊立替康(CPT-11)及其代谢产物经人肠道Caco-2细胞的主动跨上皮转运
Anticancer Drugs. 2001 Jun;12(5):419-32. doi: 10.1097/00001813-200106000-00003.
6
Effect of bile acids on the uptake of irinotecan and its active metabolite, SN-38, by intestinal cells.胆汁酸对肠道细胞摄取伊立替康及其活性代谢产物SN - 38的影响。
Biochim Biophys Acta. 2001 Feb 16;1525(1-2):125-9. doi: 10.1016/s0304-4165(00)00179-3.
7
pH-dependent uptake of irinotecan and its active metabolite, SN-38, by intestinal cells.
Int J Cancer. 1999 Nov 12;83(4):491-6. doi: 10.1002/(sici)1097-0215(19991112)83:4<491::aid-ijc10>3.0.co;2-m.
8
Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms.有机阴离子转运体OATP1B1(OATP-C)在伊立替康及其活性代谢物7-乙基-10-羟基喜树碱肝脏摄取中的作用:体外证据及单核苷酸多态性的影响
Drug Metab Dispos. 2005 Mar;33(3):434-9. doi: 10.1124/dmd.104.001909. Epub 2004 Dec 17.
9
A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor.一项关于联合使用沙利度胺(一种肿瘤坏死因子-α抑制剂)降低伊立替康毒性的机制研究。
J Pharmacol Exp Ther. 2006 Oct;319(1):82-104. doi: 10.1124/jpet.106.103606. Epub 2006 Jun 30.
10
Pharmacokinetics of orally administered camptothecins.口服喜树碱类药物的药代动力学
Ann N Y Acad Sci. 2000;922:195-204. doi: 10.1111/j.1749-6632.2000.tb07038.x.

引用本文的文献

1
Investigation into the Efficacy of Val-SN-38, a Valine-Ester Prodrug of the Anti-Cancer Agent SN-38.调查 Val-SN-38(抗癌剂 SN-38 的缬氨酸酯前药)的疗效。
Biomol Ther (Seoul). 2012 May;20(3):326-31. doi: 10.4062/biomolther.2012.20.3.326.
2
A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery.一种基于分子的伊立替康昼夜递药优化的联合实验和数学方法。
PLoS Comput Biol. 2011 Sep;7(9):e1002143. doi: 10.1371/journal.pcbi.1002143. Epub 2011 Sep 8.